RxDoctor Payments DataLook up a doctor →

Juan Lacayo, MD

Neurology · Loganville, GANPI 1245427178

Payments from drug & device makers

$164,342in general payments, 2019–2025

Across 2,344 payments — averaging $70.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$68K
  • Teva Pharmaceuticals USA, Inc.$32K
  • Biohaven Pharmaceuticals, Inc.$14K
  • Avanir Pharmaceuticals, Inc.$6K
  • SK Life Science, Inc.$4K
  • Supernus Pharmaceuticals, Inc.$4K
  • plus $36K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)398$67,893
Teva Pharmaceuticals USA, Inc.83$32,138
Biohaven Pharmaceuticals, Inc.34$14,073
Avanir Pharmaceuticals, Inc.73$5,972
SK Life Science, Inc.52$4,218
Supernus Pharmaceuticals, Inc.111$3,820
Biohaven Pharmaceutical Holding Company Ltd.18$3,616
Jazz Pharmaceuticals Inc.59$2,178
Eisai Inc.118$1,902
UCB, Inc.77$1,808
EMD Serono, Inc.77$1,483
Amgen61$1,480
MDD US Operations, LLC59$1,281
Sunovion Pharmaceuticals Inc.90$1,152
Lundbeck LLC51$1,109
Neurelis, Inc.40$1,095
Neurocrine Biosciences, Inc.40$1,038
Upsher-smith Laboratories LLC73$1,031
Lilly USA, LLC51$1,020
Catalyst Pharmaceuticals, Inc.40$1,008
Pfizer65$993
Johnson & Johnson(2 entities)32$977
Novartis81$906
Acadia Pharmaceuticals Inc46$822
AstraZeneca(2 entities)32$761
Argenx US, Inc.31$743
Sumitomo Pharma America, Inc.30$658
Otsuka America Pharmaceutical, Inc.33$651
Greenwich Biosciences, Inc.22$632
Takeda Pharmaceuticals U.S.A., Inc.31$628
Kyowa Kirin, Inc.26$538
Harmony Biosciences LLC18$501
CSL Behring20$500
Axsome Therapeutics, Inc.13$461
Amneal Pharmaceuticals LLC24$435
Sanofi23$433
Genentech USA, Inc.11$419
E.r. Squibb & Sons, L.L.C.3$348
Corium, LLC27$301
Biogen12$282
Ipsen Biopharmaceuticals, Inc10$239
Idorsia Pharmaceuticals US Inc9$237
Grifols USA, LLC11$223
Azurity Pharmaceuticals, Inc.12$206
Kedrion Biopharma, Inc.12$203
Adamas Pharmaceuticals, Inc.13$199
Acorda Therapeutics, Inc11$180
Impel Pharmaceuticals Inc.5$179
Bristol Myers Squibb7$149
Scilex Pharmaceuticals Inc.8$132
Vanda Pharmaceuticals Inc.5$104
Merz Pharmaceuticals, LLC3$89
Vertical Pharmaceuticals, LLC5$86
Ironshore Pharmaceuticals Inc.4$76
Endo Pharmaceuticals Inc.5$71
Merck5$67
Mallinckrodt Hospital Products Inc.3$67
Octapharma USA, Inc.3$67
Currax Pharmaceuticals LLC4$55
Merz North America, Inc.2$41

How this compares

$164,342 in reported general payments places this provider in the 90th percentile of 506 neurology providers in Georgia.

See all neurology providers in Georgia →

Medicare billing

Part B allowed, 2024
$329,356
Medicare patients
693
Services billed
5,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Loganville

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →